Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154058 · ClinicalTrials.gov registry record · NA
Medial Peel Release Technique TKA Randomized Clinical Trial
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05154058: Clinical Trial NA study, sponsored by Emory University.
NCT05154058 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154058, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Medial subperiosteal release is a commonly performed technique to improve surgical exposure and aid in joint balancing. This is a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) or electrocautery. The intervention will be randomly assigning subjects undergoing TKA into two groups, one receiving subperiosteal release using a scalpel (aka sharp medial peel) and the other via electrocautery.
Primary Outcome
The visual analog scale (VAS) is a tool used to measure pain. Patients will be asked to indicate their perceived pain intensity (most commonly) along a 100 mm horizontal line, and this rating is then measured from the left edge .
Interventions
- PROCEDURE Medial Subperiosteal Release with Sharp Dissection
- PROCEDURE Medial Subperiosteal Release with Electrocautery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Why NCT05154058 stopped before completion
NCT05154058 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Medial Subperiosteal Release with Sharp Dissection is the first listed.
NCT05154058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05154058 about?
NCT05154058 is a clinical study titled "Medial Peel Release Technique TKA Randomized Clinical Trial". Medial subperiosteal release is a commonly performed technique to improve surgical exposure and aid in joint balancing. This is a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) ...
What is the current status of trial NCT05154058?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2022-11-02. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT05154058?
The interventions under investigation include: Medial Subperiosteal Release with Sharp Dissection (PROCEDURE), Medial Subperiosteal Release with Electrocautery (PROCEDURE).
Who is sponsoring clinical trial NCT05154058?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05154058's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI